Nefazodone hydrochloride

CAS No. 82752-99-6

Nefazodone hydrochloride ( BMY 13754; MJ13754-1 )

Catalog No. M16074 CAS No. 82752-99-6

Nefazodone hydrochloride is an antidepressant drug.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 58 In Stock
25MG 111 In Stock
50MG 205 In Stock
100MG 309 In Stock
200MG 447 In Stock
500MG 734 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nefazodone hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Nefazodone hydrochloride is an antidepressant drug.
  • Description
    Nefazodone hydrochloride is an antidepressant drug.
  • Synonyms
    BMY 13754; MJ13754-1
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    82752-99-6
  • Formula Weight
    506.47
  • Molecular Formula
    C25H33Cl2N5O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: ~11mg/mL at60°C
  • SMILES
    O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C(CC)N1CCOC4=CC=CC=C4.[H]Cl
  • Chemical Name
    2-(3-(4-(3-chlorophenyl)piperazin-1-yl)propyl)-5-ethyl-4-(2-phenoxyethyl)-2,4-dihydro-3H-1,2,4-triazol-3-one hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bengi Uslu, et al. Analytica Chimica Acta Volume 462, Issue 1, 26 June 2002, Pages 49–57
molnova catalog
related products
  • Nelotanserin

    A potent, selective 5-HT2A inverse agonist with pKi of 9.2; displays >30- and 5000-fold selectivity compared with 5-HT2C and 5-HT2B receptors.

  • Ziprasidone

    A full antagonist of D2 and 5-HT2A receptors with Ki of 6.8 and 0.6 nM, respectively; also is a partial agonist of 5-HT1A, and a partial antagonist of 5-HT2C and 5-HT1D receptors.

  • Alosetron

    A potent and selective 5-HT3 receptor antagonist has been shown to be beneficial in the treatment of irritable bowel syndrome.